Tan S & Wang G. (2017). Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo. Dove Medical Press.
Chicago Style (17th ed.) CitationTan S and Wang G. Redox-responsive and PH-sensitive Nanoparticles Enhanced Stability and Anticancer Ability of Erlotinib to Treat Lung Cancer in Vivo. Dove Medical Press, 2017.
MLA (9th ed.) CitationTan S and Wang G. Redox-responsive and PH-sensitive Nanoparticles Enhanced Stability and Anticancer Ability of Erlotinib to Treat Lung Cancer in Vivo. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.